Adenosine 3',5'-cyclic-monophosphate dependent protein kinase and cyclic-AMP-binding in human mammary tumors. 1977

U Eppenberger, and K Talmadge, and W Küng, and E Bechtel, and J Preisz, and P Huber, and R A Jungmann, and A Salokangas

UI MeSH Term Description Entries
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D011953 Receptors, Cyclic AMP Cell surface proteins that bind cyclic AMP with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized cyclic AMP receptors are those of the slime mold Dictyostelium discoideum. The transcription regulator CYCLIC AMP RECEPTOR PROTEIN of prokaryotes is not included nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins which are the regulatory subunits of CYCLIC AMP-DEPENDENT PROTEIN KINASES. Cyclic AMP Receptors,cAMP Receptors,Cyclic AMP Receptor,Receptors, cAMP,cAMP Receptor,Receptor, Cyclic AMP,Receptor, cAMP
D001940 Breast In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES. Breasts
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic

Related Publications

U Eppenberger, and K Talmadge, and W Küng, and E Bechtel, and J Preisz, and P Huber, and R A Jungmann, and A Salokangas
July 1979, Cancer research,
U Eppenberger, and K Talmadge, and W Küng, and E Bechtel, and J Preisz, and P Huber, and R A Jungmann, and A Salokangas
December 1973, The Journal of biological chemistry,
U Eppenberger, and K Talmadge, and W Küng, and E Bechtel, and J Preisz, and P Huber, and R A Jungmann, and A Salokangas
January 1976, Biochimica et biophysica acta,
U Eppenberger, and K Talmadge, and W Küng, and E Bechtel, and J Preisz, and P Huber, and R A Jungmann, and A Salokangas
May 1973, The Journal of biological chemistry,
U Eppenberger, and K Talmadge, and W Küng, and E Bechtel, and J Preisz, and P Huber, and R A Jungmann, and A Salokangas
May 1970, Biochemical and biophysical research communications,
U Eppenberger, and K Talmadge, and W Küng, and E Bechtel, and J Preisz, and P Huber, and R A Jungmann, and A Salokangas
October 1972, The Journal of biological chemistry,
U Eppenberger, and K Talmadge, and W Küng, and E Bechtel, and J Preisz, and P Huber, and R A Jungmann, and A Salokangas
January 1980, Advances in cyclic nucleotide research,
U Eppenberger, and K Talmadge, and W Küng, and E Bechtel, and J Preisz, and P Huber, and R A Jungmann, and A Salokangas
April 1979, Biochimica et biophysica acta,
U Eppenberger, and K Talmadge, and W Küng, and E Bechtel, and J Preisz, and P Huber, and R A Jungmann, and A Salokangas
February 1977, The Journal of clinical endocrinology and metabolism,
U Eppenberger, and K Talmadge, and W Küng, and E Bechtel, and J Preisz, and P Huber, and R A Jungmann, and A Salokangas
January 1974, Biochemical Society transactions,
Copied contents to your clipboard!